Is Veru Inc (VERU) overvalued? · rev $16.9M
Veru Inc (VERU) is a biotechnology company listed on NASDAQ.
This page asks whether Veru Inc (VERU) looks expensive on cached numbers — not a short thesis.
Latest reported VERU revenue for 2024-09-30 was $16.9M. Net income was -$37.8M. Revenue was up 3.6% from 2023-09-30 to 2024-09-30. VERU currently screens at market cap $48.7M.
VERU currently screens at market cap $48.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next VERU 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the VERU stock page for the full model, not this heading.
Not investment advice.